SCHEMBL3722299

SCHEMBL3722299

COc1cncc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(Oc4ccc(OC)cc4C(F)(F)F)cn3)CC2)c1

nearest known ligand 0.46

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 6/20 0.46
BDKRB1 P46663 6/20 0.39
CACNA1I Q9P0X4 3/20 0.38
HPGDS O60760 2/20 0.37
CACNA1G O43497 2/20 0.36
CACNA1H O95180 2/20 0.36
CNR2 P34972 1/20 0.36
KCNH2 Q12809 1/20 0.36
RAF1 P04049 1/20 0.36
CTSL P07711 1/20 0.35
CTSB P07858 1/20 0.35
CTSS P25774 1/20 0.35
CTSK P43235 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3718996 0.94 CNR1 (0.44) CNR1BDKRB1CACNA1IHPGDSCACNA1G
SCHEMBL3801380 0.94 CNR1 (0.42) CNR1BDKRB1CACNA1IHPGDSCACNA1G
SCHEMBL3728225 0.94 CNR1 (0.42) CNR1BDKRB1CACNA1IHPGDSCACNA1G
SCHEMBL3722377 0.93 CNR1 (0.43) CNR1BDKRB1CACNA1IHPGDSCACNA1G
SCHEMBL13191405 0.93 BDKRB1 (0.45) CNR1BDKRB1CACNA1IHPGDSCACNA1G
SCHEMBL3722459 0.88 BDKRB1 (0.38) CNR1BDKRB1CACNA1IHPGDSCACNA1G
SCHEMBL3722282 0.87 CACNA1I (0.38) CNR1BDKRB1CACNA1IHPGDSCACNA1G
Trifluoroacetic Acid SCHEMBL3729327 0.85 CACNA1I (0.40) BDKRB1CACNA1ICACNA1GCACNA1HCNR2
SCHEMBL13191628 0.85 BDKRB1 (0.45) CNR1BDKRB1
SCHEMBL13191277 0.85 BDKRB1 (0.45) CNR1BDKRB1CACNA1ICACNA1GCACNA1H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010097373-A1 COMPOUNDS FOR USE AS BRADYKININ B1 ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-09-02 WO disclosed
WO-2010097373-A1 COMPOUNDS FOR USE AS BRADYKININ B1 ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-09-02 WO disclosed